💊
Xynocard SR
Tablet (Sustained Release)
Generic Name
Nitroglycerin
Manufacturer
The White Horse Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 3.00 (5 x 10: ৳ 150.00) Strip Price: ৳ 30.00
🔹 Indications
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Pharmacology
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Dosage & Administration
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Interaction
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Contraindications
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Side Effects
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Pregnancy & Lactation
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Precautions & Warnings
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Pediatric Usage
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
🔹 Storage Conditions
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
💡 Frequently Asked Questions
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Xynocard SR is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
User Reviews
⭐
No reviews yet!
Be the first to share your experience.